Dx dialogues: using NGS data to develop MRD assessment techniques for R/R AML

Naval Daver, MD, discusses the importance of using next-generation sequencing data.

Identifying gene mutations is an important step in diagnosing AML and determining the best approach to treatment.

An overview of the therapies used when acute myeloid leukemia (AML) doesn’t respond to treatment or comes back after treatment.

Although it’s not the most common cancer, it is among the most deadly. Here’s why—and why there’s hope for future treatments.

Why monitoring and managing protein levels in the urine is a focus of treatment for this rare kidney disease.

What to ask your healthcare providers when discussing treatment for nasal polyps, including medications and surgery.